|Bid||12.84 x 1400|
|Ask||15.00 x 800|
|Day's Range||12.53 - 12.99|
|52 Week Range||12.52 - 16.70|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Shares of BioNTech SE tumbled nearly 12% in afternoon trade, erasing all its gains from earlier on Thursday, another sign of weakness in the IPO market after the collapse of WeWork's market debut. The shares backpedalled even though the German biotech firm downsized its initial public offering (IPO) and priced its stock below an earlier expected range on Wednesday. A bout of stock market volatility fueled by worries over the potential economic impact of a trade war between the United States and China has led to IPO hopefuls delaying their listings or shares of those recently listed floundering.
Shares of BioNTech SE jumped on their market debut on Thursday, after the German biotech firm downsized its initial public offering (IPO) and priced its stock below an earlier expected range. The shares, whose launch was the latest test of fragile sentiment this year for primary stock market offerings, opened up 10% at $16.50 and rose as high as $16.69 in early trading on Nasdaq, giving the company a market valuation of $3.78 billion. The final pricing of its public flotation at $15 per ADS helped BioNtech raise about $150 million less than a month after the dramatic collapse of another major IPO for WeWork owner The We Company.
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs on Oct. 9) Aprea Therapeutics Inc (NASDAQ: APRE ) (IPOed Oct. 3) ...
BioNTech SE , a clinical-stage biotechnology company focused on patient-specific immunotherapies for the treatment of cancer and other serious diseases, today announced the pricing of its initial public offering of 10,000,000 American Depositary Shares representing 10,000,000 ordinary shares at a public offering price of $15.00 per ADS, for gross proceeds of $150,000,000.
For a more comprehensive IPO calendar, check out the offering in Benzinga Cloud . The IPO dates below are expected but not confirmed. BioNTech SE (NASDAQ: BNTX ) will issue 13.2 million shares between ...